Review Molecular Mechanisms and Treatment Options of Nephropathic Cystinosis

被引:20
|
作者
Jamalpoor, Amer [1 ]
Othman, Amr [1 ]
Levtchenko, Elena N. [2 ,3 ]
Masereeuw, Rosalinde [1 ]
Janssen, Manoe J. [1 ]
机构
[1] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, NL-3584 CG Utrecht, Netherlands
[2] Univ Hosp Leuven, Dept Pediat Nephrol & Growth & Regenerat, Leuven, Belgium
[3] Katholieke Univ Leuven, Leuven, Belgium
关键词
CHAPERONE-MEDIATED AUTOPHAGY; LYSOSOMAL STORAGE DISORDERS; RENAL PROXIMAL TUBULE; IN-VITRO EVALUATION; CYSTEAMINE BITARTRATE; CTNS GENE; INCREASED APOPTOSIS; UP-REGULATION; STEM-CELLS; H+-ATPASE;
D O I
10.1016/j.molmed.2021.04.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nephropathic cystinosis is a severe, monogenic systemic disorder that presents early in life and leads to progressive organ damage, particularly affecting the kidneys. It is caused by mutations in the CTNS gene, which encodes the lysosomal transporter cystinosin, resulting in intralysosomal accumulation of cystine. Recent studies demonstrated that the loss of cystinosin is associated with disrupted autophagy dynamics, accumulation of distorted mitochondria, and increased oxidative stress, leading to abnormal proliferation and dysfunction of kidney cells. We discuss these molecular mechanisms driving nephropathic cystinosis. Further, we consider how unravelling molecular mechanisms supports the identification and development of new strategies for cystinosis by the use of small molecules, biologicals, and genetic rescue of the disease in vitro and in vivo.
引用
收藏
页码:673 / 686
页数:14
相关论文
共 50 条
  • [1] CYSTEAMINE TREATMENT OF NEPHROPATHIC CYSTINOSIS
    WINTERBORN, MH
    GREEN, A
    TAYLOR, CM
    WHITE, RHR
    HELVETICA PAEDIATRICA ACTA, 1986, 41 (1-2) : 126 - 126
  • [2] Clinical and molecular aspects of nephropathic cystinosis
    McDowell, GA
    Town, MM
    van't Hoff, W
    Gahl, WA
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (05): : 295 - 302
  • [3] A systematic literature review of cysteamine bitartrate in the treatment of nephropathic cystinosis
    Medic, Goran
    van der Weijden, Miriam
    Karabis, Andreas
    Hemels, Michiel
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (11) : 2065 - 2076
  • [4] Clinical and molecular aspects of nephropathic cystinosis
    Geraldine A. McDowell
    Margaret M. Town
    William van’t Hoff
    W. A. Gahl
    Journal of Molecular Medicine, 1998, 76 : 295 - 302
  • [5] TREATMENT OF INFANTILE NEPHROPATHIC CYSTINOSIS WITH CYSTEAMINE
    POCECCO, M
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (20): : 1320 - 1320
  • [6] Pharmacological treatment of nephropathic cystinosis with cysteamine
    Kleta, R
    Gahl, WA
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (11) : 2255 - 2262
  • [7] The molecular basis of Dutch infantile nephropathic cystinosis
    Heil, SG
    Levtchenko, E
    Monnens, LAH
    Trijbels, FJM
    Van der Put, NMJ
    Blom, HJ
    NEPHRON, 2001, 89 (01) : 50 - 55
  • [8] Adult complications of nephropathic cystinosis: a systematic review
    Rachel Nora Kasimer
    Craig B Langman
    Pediatric Nephrology, 2021, 36 : 223 - 236
  • [9] TREATMENT OF INFANTILE NEPHROPATHIC CYSTINOSIS WITH OXIDIZED DITHIOTHREITOL
    GOODYER, PR
    READE, T
    LANCASTER, G
    SCRIVER, CR
    PEDIATRIC RESEARCH, 1987, 21 (04) : A476 - A476
  • [10] Adult complications of nephropathic cystinosis: a systematic review
    Kasimer, Rachel Nora
    Langman, Craig B.
    PEDIATRIC NEPHROLOGY, 2021, 36 (02) : 223 - 236